Belanoff Joseph K

Belanoff Joseph K is listed in filings as Chief Executive Officer at Corcept Therapeutics Incorporated. This profile follows SEC Form 4 activity through Jun 2, 2026, including sale activity. Recent filings connect the profile to Corcept Therapeutics Incorporated (CORT). The current snapshot covers public activity from Jul 21, 2025 to Jun 2, 2026. Reported amounts are shown as $45.3K to $1.2M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.